1. Home
  2. NVCR vs RAMP Comparison

NVCR vs RAMP Comparison

Compare NVCR & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • RAMP
  • Stock Information
  • Founded
  • NVCR 2000
  • RAMP 2018
  • Country
  • NVCR Switzerland
  • RAMP United States
  • Employees
  • NVCR N/A
  • RAMP N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • RAMP EDP Services
  • Sector
  • NVCR Health Care
  • RAMP Technology
  • Exchange
  • NVCR Nasdaq
  • RAMP Nasdaq
  • Market Cap
  • NVCR 1.9B
  • RAMP 1.8B
  • IPO Year
  • NVCR 2015
  • RAMP 1987
  • Fundamental
  • Price
  • NVCR $17.60
  • RAMP $32.51
  • Analyst Decision
  • NVCR Buy
  • RAMP Buy
  • Analyst Count
  • NVCR 7
  • RAMP 8
  • Target Price
  • NVCR $32.43
  • RAMP $39.38
  • AVG Volume (30 Days)
  • NVCR 1.4M
  • RAMP 493.9K
  • Earning Date
  • NVCR 07-24-2025
  • RAMP 08-06-2025
  • Dividend Yield
  • NVCR N/A
  • RAMP N/A
  • EPS Growth
  • NVCR N/A
  • RAMP N/A
  • EPS
  • NVCR N/A
  • RAMP N/A
  • Revenue
  • NVCR $621,711,000.00
  • RAMP $745,580,000.00
  • Revenue This Year
  • NVCR $5.56
  • RAMP $10.01
  • Revenue Next Year
  • NVCR $9.19
  • RAMP $9.39
  • P/E Ratio
  • NVCR N/A
  • RAMP N/A
  • Revenue Growth
  • NVCR 18.27
  • RAMP 13.03
  • 52 Week Low
  • NVCR $14.17
  • RAMP $21.45
  • 52 Week High
  • NVCR $34.13
  • RAMP $36.08
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 49.74
  • RAMP 50.93
  • Support Level
  • NVCR $16.81
  • RAMP $33.18
  • Resistance Level
  • NVCR $18.59
  • RAMP $34.50
  • Average True Range (ATR)
  • NVCR 0.74
  • RAMP 0.87
  • MACD
  • NVCR 0.08
  • RAMP -0.06
  • Stochastic Oscillator
  • NVCR 56.18
  • RAMP 54.57

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a global technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust.

Share on Social Networks: